1. Home
  2. EWTX vs LPL Comparison

EWTX vs LPL Comparison

Compare EWTX & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$33.00

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

HOLD

Current Price

$4.52

Market Cap

3.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EWTX
LPL
Founded
2017
1985
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.9B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
EWTX
LPL
Price
$33.00
$4.52
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$39.00
N/A
AVG Volume (30 Days)
739.7K
2.2M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.04
Revenue Next Year
N/A
$3.00
P/E Ratio
N/A
$25.64
Revenue Growth
N/A
N/A
52 Week Low
$11.50
$2.72
52 Week High
$34.00
$5.67

Technical Indicators

Market Signals
Indicator
EWTX
LPL
Relative Strength Index (RSI) 58.59 60.45
Support Level $28.72 $4.16
Resistance Level N/A $5.07
Average True Range (ATR) 1.48 0.20
MACD 0.15 0.06
Stochastic Oscillator 76.47 94.41

Price Performance

Historical Comparison
EWTX
LPL

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

Share on Social Networks: